Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,505 | 724 | 99.4% |
| Education | $80.34 | 3 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,852 | 133 | $0 (2024) |
| Lilly USA, LLC | $1,319 | 107 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,224 | 63 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,066 | 44 | $0 (2023) |
| Astellas Pharma US Inc | $993.45 | 56 | $0 (2024) |
| ABBVIE INC. | $826.78 | 31 | $0 (2024) |
| PFIZER INC. | $605.29 | 34 | $0 (2024) |
| Allergan, Inc. | $527.85 | 10 | $0 (2020) |
| GlaxoSmithKline, LLC. | $375.49 | 25 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $361.23 | 21 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,160 | 59 | Astellas Pharma US Inc ($239.59) |
| 2023 | $1,863 | 93 | ABBVIE INC. ($264.12) |
| 2022 | $1,918 | 87 | ABBVIE INC. ($356.90) |
| 2021 | $2,157 | 126 | Novo Nordisk Inc ($388.59) |
| 2020 | $1,007 | 57 | AstraZeneca Pharmaceuticals LP ($191.95) |
| 2019 | $2,204 | 118 | Allergan Inc. ($364.13) |
| 2018 | $2,104 | 119 | Boehringer Ingelheim Pharmaceuticals, Inc. ($337.25) |
| 2017 | $1,172 | 68 | PFIZER INC. ($206.63) |
All Payment Transactions
727 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Gastroenterology | ||||||
| 12/19/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Diabetes | ||||||
| 12/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Biological | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Obesity | ||||||
| 10/24/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $28.56 | General |
| Category: Transcatheter Heart Valves | ||||||
| 10/10/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: VACCINES | ||||||
| 10/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Biological | ||||||
| 09/30/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Bone Health | ||||||
| 09/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: PSYCHIATRY | ||||||
| 09/23/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Oncology | ||||||
| 09/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: Obesity | ||||||
| 09/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Biological | ||||||
| 09/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | ALK-Abello, Inc | Odactra (Drug), Grastek, Ragwitek | Food and Beverage | In-kind items and services | $25.43 | General |
| Category: Allergy and Immunology | ||||||
| 08/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Diabetes | ||||||
| 08/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: Gastroenterology | ||||||
| 08/05/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Biological | ||||||
| 07/25/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: Oncology | ||||||
| 07/22/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 662 | 793 | $138,047 | $71,219 |
| 2022 | 15 | 752 | 1,144 | $192,545 | $93,656 |
| 2021 | 15 | 1,168 | 1,628 | $279,435 | $130,769 |
| 2020 | 17 | 867 | 1,076 | $180,856 | $76,516 |
All Medicare Procedures & Services
70 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 106 | 110 | $27,940 | $15,448 | 55.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 89 | 89 | $35,600 | $11,120 | 31.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 28 | 28 | $8,960 | $7,906 | 88.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 80 | 89 | $15,130 | $7,721 | 51.0% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 54 | 80 | $10,960 | $6,299 | 57.5% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 45 | 104 | $10,816 | $5,620 | 52.0% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 41 | 69 | $9,453 | $5,590 | 59.1% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 24 | 27 | $6,858 | $3,692 | 53.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 40 | $4,800 | $2,299 | 47.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 28 | 28 | $2,380 | $2,014 | 84.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 34 | 34 | $1,330 | $958.25 | 72.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 52 | 52 | $1,300 | $925.08 | 71.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 28 | 28 | $960.00 | $824.52 | 85.9% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 13 | 15 | $1,560 | $802.76 | 51.5% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 129 | 137 | $34,798 | $17,348 | 49.9% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 70 | 235 | $32,195 | $15,762 | 49.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 97 | 97 | $38,800 | $12,433 | 32.0% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 59 | 186 | $25,482 | $12,408 | 48.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 80 | 88 | $14,588 | $7,929 | 54.4% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 36 | 51 | $8,925 | $5,231 | 58.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 18 | 18 | $5,220 | $5,013 | 96.0% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Office | 2022 | 25 | 25 | $6,350 | $3,110 | 49.0% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 20 | 58 | $6,032 | $3,027 | 50.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 44 | $4,878 | $2,770 | 56.8% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 24 | 48 | $4,992 | $2,225 | 44.6% |
About Dr. Stacey Gugino, MD
Dr. Stacey Gugino, MD is a Family Medicine healthcare provider based in Williamsville, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1346438157.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stacey Gugino, MD has received a total of $13,585 in payments from pharmaceutical and medical device companies, with $1,160 received in 2024. These payments were reported across 727 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($13,505).
As a Medicare-enrolled provider, Gugino has provided services to 3,449 Medicare beneficiaries, totaling 4,641 services with total Medicare billing of $372,161. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Williamsville, NY
- Active Since 10/05/2007
- Last Updated 02/02/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1346438157
Products in Payments
- JARDIANCE (Drug) $727.33
- Ozempic (Drug) $719.41
- TRULICITY (Drug) $656.53
- FARXIGA (Drug) $624.81
- UBRELVY (Drug) $427.28
- XARELTO (Drug) $319.34
- Saxenda (Drug) $311.06
- Wegovy (Drug) $298.30
- VRAYLAR (Drug) $269.07
- CHANTIX (Drug) $267.74
- Myrbetriq (Drug) $265.86
- Veozah (Drug) $264.10
- Vascepa (Drug) $260.14
- ELIQUIS (Drug) $256.46
- Victoza (Drug) $248.12
- TRADJENTA (Drug) $241.22
- QULIPTA (Drug) $232.68
- ZENPEP (Drug) $222.84
- ENTRESTO (Drug) $220.92
- DALVANCE (Drug) $210.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Williamsville
Jean Cange, M.d, M.D
Family Medicine — Payments: $28,012
Dr. Daniel Trock, M.d, M.D
Family Medicine — Payments: $22,227
Suchitra Koneru, M.d, M.D
Family Medicine — Payments: $15,123
Dr. David Pawlowski, Md, MD
Family Medicine — Payments: $14,600
Dr. Karol Pohlman Rejman, Phd, Fnp, PHD, FNP
Family Medicine — Payments: $12,074
Dr. Michael Dlugosz, M.d, M.D
Family Medicine — Payments: $11,462